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ING4 belongs to a family of proteins that have been implicated in tumor
suppression and has been linked to the activation of p53 target genes in a p53dependent manner. However the mechanism by which it interacts with p53 to
activate transcription from these genes is unclear. In this study I use in vitro
reconstitutions of cellular processes to biochemically dissect the activity of the
ING4 complex, complementing the cell based assays that give a more
physiological but less defined window into ING4’s effect on p53 transcriptional
activity. Purification of the ING4 complex allowed verification of previously known
subunits and identification of BRPF1/2/3 as a core ING4 component.
Reconstitution of the ING4 complex allowed the identification of two distinct
variants of the ING4 complex which utilized either JADE or BRPF as the central
scaffold subunit. Both these variants were required to recapitulate the histone
acetyltransferase activity of the endogenous complex. Using these complexes, I
demonstrate that the ING4 complex histone modifying activity is not directly
affected by p53 but is rather indirectly modulated through p53-dependent p300
activity and enhanced by the presence of the p53-dependent trimethylated H3K4
histone mark. I also establish an ING4 complex-mediated p53-dependent

transcription system on chromatin templates and show that the ING4 complex
has a direct effect on p53 dependent transcription. Additionally, the same
conditions that enhance ING4 complex histone acetylation, namely p300 and
trimethylated H3K4, also enhance the ING4 complex’ effects on p53 dependent
transcription. Taken together, these results establish ING4 as a transcriptional
coactivator of p53 and suggest two mechanisms by which p53 affects ING4
complex histone modification and transcriptional activity.
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Chapter 1

Introduction
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1.1 Histone modifications and transcription
The question of how the same genetic code can carry out such disparate
activities such as differentiation, development and homeostasis is one that is of
great interest. There is no difference in the genetic blueprint between a nerve
cell, a liver cell, a muscle cell, or a skin cell, yet in accordance with their function,
these cells demonstrate great phenotypic differences. The same phenomenon
can also be observed temporally within the same cell where different reactions
occur in response to different stimuli despite the same genome being present
throughout. A major key to this dichotomy is through the differential expression of
genes (Roeder, 2003). The mechanism by which gene expression is regulated is
thus of great interest in understanding how a cell functions and in understanding
and treating a variety of diseases that have their root cause in the misregulation
of gene expression (Bhatia & Kleinjan, 2014).

There are many different mechanisms by which the transcriptional
activation of genes may be regulated. These range from those that function at
the level of DNA, such as sequence specific DNA binding transcription factors
that recruit RNA polymerases and other transcriptional machinery, to those that
function at the level of chromatin, such as the chromatin structure itself which
affects different conformations to either repress or allow transcription (Roeder,
2005). The numerous post-translational modifications on histone proteins in
chromatin such as acetylation, methylation, phosphorylation and ubiquitination
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have been proposed to form a histone code that exists alongside the genetic
code and allows for an additional level of transcriptional regulation (Strahl & Allis,
2000). More specifically, histone acetylation has been highly correlated with
transcriptional activation (Roth, et al., 2001; Li, et al., 2007) while H3K4
trimethylation in particular is associated with the 5’ regions of active genes and is
strongly correlated with histone acetylation and transcription (Ruthenburg, et al.,
2007a). However the precise mechanisms behind the establishment of these
marks and their effect on transcription have not been fully elucidated.

1.2 The transcription factor p53
p53 is a classical transcriptional activator that binds to response elements
contained within p53 target genes. As a tumor suppressor, it modulates the
cellular response to a wide array of stresses (Levine, et al., 2006) and mediates
the transcriptional activation of numerous target genes, amongst them those that
activate the cell cycle arrest and apoptosis pathways, such as p21 and BAX
(Laptenko & Prives, 2006). As such, it is frequently found to be mutated or
otherwise downregulated in a variety of cancers (Levine, et al., 2006).

While p53 itself has no intrinsic histone modifying capability, many p53
cofactors are capable of post-translational protein modification and have had
these capabilities linked to their role as cofactors of p53-mediated transcription.
The p53 cofactor p300, for example, is capable of acetylating chromatin in a p533

dependent manner, and this acetylation is essential for p300 mediation of p53dependent transcription (Espinosa & Emerson, 2001; An, et al., 2004).
Methyltransferases such as SET1 and MLL have also been shown to affect
transcription via methylation of H3K4 (Dou, et al., 2005; Jiang, et al., 2013; Tang,
et al., 2013), a modification that is also affected by RAD6 ubiquitylation of H2B
(Kim, et al., 2009). One pathway by which p53 regulates the transcription of its
target genes is therefore through modification of histones via the activity of its
cofactors.

1.3 Inhibitor of Growth (ING) proteins
1.3.1 Discovery of ING proteins
The Inhibitor of Growth (ING) family of proteins are a homologous group of
proteins that when ectopically expressed in cells, as their name suggests, inhibit
the growth of cells. The founding member, ING1, was first identified from a
genetic suppressor element isolated in a subtractive hybridization assay that
compared normal mammary epithelium and several breast cancer cell lines. A
screen for genetic elements that were differentially expressed in the cancer cell
lines and had an effect on cell growth resulted in the identification of ING1
(Garkavtsev, et al., 1996). Four other members of the ING family (INGs 2-5) were
subsequently identified via sequence homology and characterized as having
several similar structural features, foremost of which is a highly conserved PHD
finger (Fig 1A & 1B) (Coles & Jones, 2009). All members were also found to have
4

Fig 1. The Inhibitor of Growth family of proteins.
A) Structural motifs of the ING family of proteins. PIP – PCNA interacting protein
motif. PBD – Partial bromodomain. LZL – Leucine zipper-like region. NCR –
Novel conserved region. NLS – Nuclear localization sequence. PHD – Plant
homeodomain. PBR – Poly basic region.
B) Sequence alignment of ING family proteins showing the highly conserved
PHD finger domain in yellow.
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Fig 1A

6

Fig 1B

7

Table 1. ING complex members.

8

the same inhibitory effect on cell growth (Shimada, et al., 1998; Nagashima, et
al., 2001; Gunduz, et al., 2002; Nagashima, et al., 2003; Shiseki, et al., 2003).

1.3.2 Characteristics of ING proteins
In addition to their sequence homology and their ability to inhibit cell
growth when expressed, all ING proteins have several characteristics in
common. Each is a member of a multisubunit protein complex that possesses a
histone modifying capability- histone deacetylase in the case of ING1 and ING2,
and histone acetyltransferase in the case of INGs 3, 4 and 5 (Table 1) (Skowyra,
et al., 2001; Kuzmichev, et al., 2002; Doyon, et al., 2004; Doyon, et al., 2006).
Secondly, each possesses a conserved Plant Homeodomain zinc-finger (PHD
finger) that has been shown in several proteins to recognize and bind
preferentially to trimethylated, and to a lesser extent dimethylated, H3K4 (Shi, et
al., 2006; Li, et al., 2006; Wysocka, et al., 2006). In the case of ING4, this is
accomplished via an aromatic cage that interacts with the trimethylammonium
group of H3K4 (Pena, et al., 2006). This ability to discriminate between
trimethylated H3K4 and the other methylation states of H3K4 identifies the ING
proteins as ‘readers’ of the histone code. In conjunction with the catalytic ability
associated with their complexes, the ING proteins thus provide an effector
pathway by which the H3K4 trimethylation mark might be translated into some
downstream activity (Ruthenburg, et al., 2007a).

9

1.3.3 Association with p53
The ING protein family as a whole has also been implicated in the
regulation of several p53-activated pathways. The ING-mediated inhibitory
effects on cell growth were dependent on p53 in the majority of cases and a
synergistic inhibitory effect on cell growth was observed with several of the ING
proteins when they were co-expressed with p53. Additionally, all ING proteins,
with the exception of ING3, have been shown to co-immunoprecipitate with p53.
ING proteins thus show a physical and functional interaction with p53 (Coles &
Jones, 2009). Altogether these observations suggest that the ING proteins might
play a role as p53 cofactors.

1.4 The ING4 protein
1.4.1 Characteristics of the ING4 protein
The fourth member of the ING family, ING4, is of particular interest
because the complex it exists in includes a histone acetyltransferase (Doyon, et
al., 2006). This, together with its H3K4 trimethyl recognizing PHD finger, raises
the possibility of cross-talk between trimethylated H3K4me3 and histone
acetylation. Additionally, the ING4 protein complex consists of a limited number
of subunits, which makes complete reconstitution of the complex a more
tractable problem. Finally, unlike the ING5 complex, the ING4 complex is thought
to be primarily involved in transcription regulation, rather than both transcription
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and DNA replication (Doyon, et al., 2006). For these reasons the decision was
made to focus this study on the fourth member of the ING family of proteins.

ING4 is frequently found to be downregulated in cancers and its
expression has been inversely correlated with cancer progression and severity
(Piche & Li, 2010). As with other members of the ING family, ING4 has been
implicated in p53 mediated gene expression and DNA damage responses. More
specifically, ING4 coimmunoprecipitates with p53 and ectopic expression of ING4
has been shown to result in reduced colony formation, cell cycle arrest and
apoptosis. Activation of the p21 and BAX promoters and expression of
endogenous p21 and BAX were also induced by ectopic ING4 expression in a
p53-dependent manner (Shiseki, et al., 2003; Zhang, et al., 2004; Doyon, et al.,
2006; Avvakumov, et al., 2012). These observations suggest that ING4 can
function as a transcriptional coactivator of p53 in the regulation of these
pathways.

However, two other studies concluded that overexpression of ING4 also
conferred inhibitory effects in the p53 mutated T47D and U-118MG cell lines
(Kim, et al., 2004; Unoki, et al., 2006). Additionally, ING4 has also been
associated with the transcription factors NF-κB and HIF-1α. This suggests that
ING4 has additional functions independent of p53, possibly as a cofactor to other
transcription factors. However the mechanism by which it functions as a cofactor
11

in these other cases is unlikely to be the same since in these cases it seems to
function as a negative cofactor, repressing the functions of both NF-κB and HIF1α (Garkavtsev, et al., 2004; Ozer, et al., 2005), rather than as a positive factor,
as in the case of p53 and the activation of p21 and BAX.

With respect to ING4’s occupancy on genes, ectopically expressed ING4
was found to be enriched around the transcription start sites (TSS) of DNA
damage activated promoters in response to doxorubicin treatment. This
correlates with the pattern of enrichment of trimethylated H3K4 and is dependent
on the trimethylated H3K4 recognizing ING4 PHD finger. This suggests that the
PHD-trimethylated H3K4 interaction is important for the recruitment of ING4 to
such promoters (Hung, et al., 2009) and further supports the role of ING4 as a
transcriptional cofactor.

1.4.2 Structure of the ING4 protein
ING4 is a ~29kDa protein 249 amino acids in length (Fig 2A). It contains
an N-terminal leucine zipper-like (LZL) region, a unique region that is conserved
amongst the INGs termed the novel conserved region (NCR), a C-terminal plant
homeodomain (PHD) zinc finger and two nuclear localization signals (NLS). The
LZL region is thought to mediate dimerization between two ING4 molecules and
potentially between ING4 and ING5 molecules (Palacios, et al., 2010; Culurgioni,
et al., 2012). The ING4 PHD finger, as with all other ING PHD fingers, has been
12

Fig 2. The ING4 complex.
A) Domain structure of the ING4 complex subunits. PHD – Plant homeodomain
finger. Bromo – bromodomain. PWWP – Pro-Trp-Trp-Pro motif. S – Serine rich
region. ZF – Zinc finger. MYST – histone acetyltransferase domain. LZL –
Leucine zipper like region. NCR – Novel conserved region. NLS – Nuclear
localization signal. LZ – Leucine zipper.
B) Schematic representation of the JADE1S-HBO1 complex and the JADE1LHBO1-ING4-hEAF6 complex.
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Fig 2A

Fig 2B
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shown to bind specifically to histone trimethylated H3K4 (Shi, et al., 2006;
Palacios, et al., 2008; Hung, et al., 2009), while the first NLS (NLS1) is thought to
play a role in the ING4-p53 interaction (Zhang, et al., 2005). However, another
study failed to find any significant p53 interaction (Palacios, et al., 2010). The
PHD domain, the NCR and the first NLS are conserved amongst all the INGs,
while the LZL region is absent from ING1 and the second C-terminal NLS is
present only in ING 4 and 5 (Coles & Jones, 2009).

In addition to the full length ING4, multiple splice variants of the ING4
transcript have been detected. The ING4 proteins that were expressed from
three of these variants had a missing or truncated NLS1 and were shown to
localize predominantly to the cytoplasm instead of the nucleus (Unoki, et al.,
2006). However, other variants that also modified NLS1 did not affect the nuclear
localization, but rather affected the localization of ING4 within the nucleus (Tsai,
et al., 2008). Curiously, the presence of the second C-terminal NLS (NLS2)
appeared to be dispensable for nuclear localization, suggesting a non-functional
NLS (Unoki, et al., 2006). Three more variants that included either an intact or
slightly shorter NLS1 were also shown to localize to the nucleus and to maintain
their interaction to p53 and HBO1 (Raho, et al., 2007). While the existence of
these naturally occurring alternatively spliced proteins has yet to be detected,
these studies do suggest that the NLS1 is responsible for the nuclear localization
of ING4.
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1.5. The ING4 Complex
1.5.1 Components of the ING4 complex
The ING4 complex consists of ING4 itself and three additional proteins: 1)
the MYST family histone acetyltransferase HBO1 (histone acetyltransferase
binding to ORC1), 2) a member of the JADE (gene for apoptosis and
differentiation in epithelia) protein family, JADE1L/2/3, and 3) the uncharacterized
protein hEaf6 (Fig 2A), which is also present in the ING3-Tip60 complex, the
ING5-HBO1 complex, and the ING5-MOZ/MORF complex (Fig 1B) (Doyon, et
al., 2006). Additional interactions have also been identified with other proteins
such as NF-κB and p300 (Garkavtsev, et al., 2004; Shiseki, et al., 2003), but
these are lost when the ING4 complex is more stringently purified and are not
thought to be integral components of the ING4 complex (Doyon, et al., 2006).

1.5.1.1 HBO1
HBO1 is a MYST family histone acetyltransferase that has been
implicated in DNA replication as well as transcription (Burke, et al., 2001; Iizuka,
et al., 2006; Georgiakaki, et al., 2006; Miotto & Struhl, 2006). It is a member of
both ING4 and ING5 complexes (Doyon, et al., 2006) and has been shown to
interact with p53 (Iizuka, et al., 2008). HBO1 is thought to be responsible for
significant proportion of histone H4 acetylation in the cell at lysine residues 5, 8
and 12, but not 16, in 293 cells (Doyon, et al., 2006) and for H3K14 acetylation in
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mouse primary embryonic fibroblasts and erythroblasts (Kueh, et al., 2011;
Mishima, et al., 2011).

1.5.1.2 JADE
Of the JADE protein members of the complex, the JADE1 homolog has
been the most extensively studied. JADE1 exists as two isoforms – a full length
protein of 842 amino acids termed JADE1L, and a truncated version of 509
amino acids termed JADE1 or JADE1S. The full length JADE1L isoform is
associated with the full ING4 complex while the truncated JADE1S isoform is
associated only with HBO1, forming a smaller JADE1S-HBO1 complex that lacks
ING4 and hEaf6 (Fig 2B). Both JADE1 isoforms possess two PHD domains, the
first of which, PHD1, binds preferentially to unmethylated H3K4 and
demonstrates a slight preference for trimethylated H3K36. The second PHD
domain, PHD2, binds independently of H3K4 methylation status and is thought to
be essential for both the JADE1S complex and the larger JADE1L/2/3-ING4
complex’ association with chromatin. It is also thought to be necessary for
JADE1L’s inhibitory effects on cell growth (Foy, et al., 2008; Saksouk, et al.,
2009).

17

1.5.1.3 BRPF
More recently, BRPF1/2/3, which was previously identified as a member of
the ING5 complex, has been identified as an ING4 associated protein (Mishima,
et al., 2011). However, the precise relationship of BRPF1/2/3 to ING4 and to the
other ING4 subunits has yet to be fully elucidated. All BRPF paralogs have 2
PHD fingers, with the PHD fingers of BRPF2 (which is more commonly known as
BRD1), being the most extensively studied. Similar to the JADE PHD fingers, the
first BRD1 PHD finger binds preferentially to unmethylated H3K4 while the
second PHD finger seems to interact with H3 independent of H3K4 methylation
(Qin, et al., 2011; Lalonde, et al., 2013) and has also been shown to be capable
of binding nonspecifically to DNA (Liu, et al., 2012). Based on conservation of
key residues, it is possible that this is also a property of the JADE PHD2
domains, although this has not been shown. Additionally, all BRPF proteins
possess a bromodomain that binds acetyl-lysines (Sanchez & Zhou, 2009), and a
PWWP domain, that has an affinity for trimethylated H3K36 (Vezzoli, et al.,
2010).

1.5.2 Trimethylated H3K4-dependent acetylation
Through its subunits, the ING4 complex possesses multiple chromatin
readers (Table 2). These readers, combined with the histone acetylating HBO1
suggests that the ING4 complex as a whole could function as an effector,
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Table 2. Chromatin binding domains of the ING4 complex.
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mediating its histone acetylation activity in response to one or more of these
marks. Indeed, similar to what has been observed with the orthologous yeast
NuA3 complex (Taverna, et al., 2006), ING4 complex mediated increase in H3
acetylation in response to trimethylated H3K4 has been demonstrated on H3
peptides and reconstituted nucleosomes (Hung, et al., 2009). A similar increase
was also shown with the homologous ING5 complex on oligonucleosomes
purified from yeast (Saksouk, et al., 2009). There is thus an ING4 complexmediated link between trimethylated H3K4 and H3 acetylation (Fig 3), and
through this histone acetylation, between trimethylated H3K4 and transcriptional
activation.

20

Fig 3. ING4 complex mediates H3K4me3-dependent H3 acetylation
The ING4 complex HBO1 subunit acetylates H4 independent of H3K4
methylation status. Recognition of H3K4me3 by the ING4 PHD finger mediates
H3 acetylation in addition to the H3K4me3 independent H4 acetylation. Blue
arrows represent histone acetylation activity by the HBO1 subunit of the ING4
complex and point to the resulting histone acetylation. The black arrow
represents the interaction between the ING4 PHD finger and H3K4me3. H3ac:
Acetylation on H3. H4ac: Acetylation on H4. H3K4me3: Trimethylated H3K4
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Chapter 2

Composition and Structure of the
ING4 complex
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2.1 Preface
The ING4 complex was first purified by Doyon et al via TAP-tag ING4
purification and was determined to be composed of the subunits JADE1L/2/3,
HBO1, ING4 itself, and hEAF6 (Fig 1B) (Doyon, et al., 2006). Other studies have
looked at the interactions between the various subunits within the ING4 and
homologous ING5 complexes, using co-immunoprecipitation of ectopically
expressed proteins and in vitro binding of recombinant proteins (Foy, et al., 2008;
Saksouk, et al., 2009; Avvakumov, et al., 2012; Lalonde, et al., 2013). These
studies showed that there is a JADE1-HBO1 interaction, and that additional
interactions with ING4 and hEAF6 are mediated through the C-terminal of
JADE1L that is absent in the shorter JADE1S isoform (Fig 4A). This arrangement
is similar to that of the ING5-BRPF complex, where the central BRPF is
responsible for bridging the catalytic MOZ/MORF and ING5/hEAF6 (Fig 4B)
(Ullah, et al., 2008).

A subsequent BRD1 (BRPF2) immunoprecipitation by Mishima et al
showed the existence of a BRD1 containing ING4-HBO1 complex (Mishima, et
al., 2011) that was undetected in the original purification (Doyon, et al., 2006).
The association with ING4 and HBO1 was subsequently also shown to occur
with the BRPF1 and BRPF3 paralogs (Lalonde, et al., 2013). Together these
results suggest the existence of an ING4 complex that can include a BRPF
subunit.

24

Fig 4. Interactions between ING4 and ING5 complex subunits.
A) Interactions between the subunits of the JADE1S complex and the JADE1LING4 complex. The shorter JADE1S protein is unable to interact with ING4 and
hEAF6.
B) Interactions between the subunits of BRPF-ING5 complex.
Arrows represent protein interactions. Crossed out arrows represent interactions
that are no longer possible for the JADE1S protein.
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However many of the assays used in these studies relied upon
overexpression of all subunits of interest in human 293T cells, followed by
coimmunoprecipitation and analysis by Western blots (Hung, et al., 2009;
Saksouk, et al., 2009; Avvakumov, et al., 2012; Lalonde, et al., 2013). While this
approach allows for identification of specific proteins that are present in the
immunoprecipitate, is inherently biased as the only proteins that will be identified
are the proteins that are blotted for. It does not allow the conclusion that these
identified proteins directly interact with each other - other yet to be identified
proteins in the immunoprecipitate could be responsible for mediating the
interactions of the identified proteins.

Additionally, as noted in the original ING4 complex purification,
overexpression of a protein can lead to non-specific (Doyon, et al., 2006), as well
as specific interactions with endogenous contaminating proteins. This problem is
compounded by the large number of permutations of the ING4 complex that can
occur, with possible interactions with both JADE and BRPF (Doyon, et al., 2006;
Mishima, et al., 2011; Lalonde, et al., 2013). Dimerization between ING4 and
ING5 proteins (Palacios, et al., 2010; Culurgioni, et al., 2012) allow for additional
contamination by both ING5 as well as ING5 associated proteins such as
MOZ/MORF (Doyon, et al., 2006; Ullah, et al., 2008).
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The precise composition of an ING4 complex reconstituted and
characterized in this manner from 293T cells is therefore unclear. In addition to
the desired subunits, the final immunoprecipitate could also include endogenous
JADE, BRPF, HBO1, and hEAF6 via interactions with the ING4 subunit. If ING4
can form heterodimers with ING5, this complex could also contain ING5 and
ING5-associated proteins such as MOZ/MORF. A JADE-HBO1-ING4-hEAF6
complex reconstituted in this manner could therefore also include BRPF,
MOZ/MORF, and ING5, leading to a heterogenous mixture of complexes rather
than a homogenous purification of JADE-HBO1-ING4-hEAF6. Caution must
therefore be taken in any conclusions drawn regarding the complexes purified or
reconstituted in this manner.

To circumvent these risks of contamination and to obtain a better
understanding of ING4 complex composition, we therefore set out to purify the
ING4 complex with minimal expression of ectopic proteins. We also intended to
reconstitute the ING4 complex in a non-mammalian system, allowing a cleaner
analysis of protein-protein interactions without the risk of contaminating
mammalian proteins.
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2.2 Composition of the ING4 complex
2.2.1 Purification of ING4 and associated proteins
To purify the ING4 complex a HeLa Tet-on cell line (Tang, et al., 2013)
was first established that uses doxycycline to induce expression of ectopic
FLAG-tagged ING4 (f:ING4). Conditions were then established under which
ectopic ING4 expressed was low – to an equivalent level as endogenous ING4
(Fig 5A). Nuclear extract (NE) from the cells were made and the FLAG-ING4 and
its associated proteins were subsequently purified.

Initial attempts to purify the ING4 complex using M2-affinity purification on
nuclear extract (Fig 5B) made from the f:ING4 cell line (Dignam, et al., 1983)
were unsuccessful, with elution of the ‘complex’ at the final step containing little
ING4 (Fig 5C). Analysis of ING4 levels at each step of the purification process
identified the dialysis step during the nuclear extract procedure, where the salt
concentration was brought down to 100mM KCl, as the point where the majority
of the ING4 was lost (Fig 5D). Attempts to locate the missing ING4 were
unsuccessful – treating of the pellet obtained from centrifugation extract postdialysis with high salt buffer did not reveal the presence of any great amount of
ING4 (data not shown). However, this loss could be circumvented by modifying
the dialysis step to a higher salt dialysis. A dialysis to 300mM KCl resulted in a
low enough salt concentration for the subsequent purification step without any
observable loss of ING4 from the nuclear extract (Fig 6A & 6B).
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Fig 5. ING4 complex purification from low salt nuclear extract.
A) Doxycycline induction of FLAG-tagged ING4. Doxycycline was titrated over
range of concentration from 100 to 1200ng/ml to obtain expression of ectopic
FLAG-ING4 (upper band) approximately equivalent to endogenous ING4 (lower
band) (indicated by arrow) (Western blot with indicated antibody)
B) Outline of initial ING4 complex purification strategy from nuclear extract
dialysed to 100mM KCl.
C) Silver stain of the initially purified ‘ING4 complex’ compared to a mock M2
affinity purification conducted on HeLa nuclear extract in which the ectopically
expressed FLAG-ING4 was not expressed.
D) ING4 in nuclear extract at high and low salt showing loss of ING4 during the
dialysis process. (Western blot with indicated antibody)
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ING4 complex purified from the nuclear extract contained bands that
corresponded to the molecular weights of expected proteins, but also included
several other contaminating bands that were also present in the mock purification
(Fig 6C). A P11 ion exchange chromatography step was therefore added to the
purification (Fig 6D). Both ING4 and HBO1 were found to elute from the column
with the 500mM KCl fraction (Fig 6E). This fraction was dialysed again to 300mM
KCl and subjected to M2 affinity purification to give a purified ING4 complex
(termed ING4C, with ‘ING4 complex’ hereafter referring to ING4 complex(es) in
general).

2.2.2 Verification of basic components
The purified ING4C was analyzed by silver stain which revealed bands
that correspond to the approximate molecular weights of JADE1L/2/3, HBO1,
ING4 and hEAF6 (Fig 6F, slices 5, 7, 12 & 13). Western blot further verified the
presence of ING4 and HBO1 (Fig 6G). Analysis of the purified ING4C by mass
spectrometry conducted by the Rockefeller University Proteomics Resource
Center confirmed the identities of JADE1L/2/3, HBO1, ING4 and hEAF6,
suggesting that the M2 immunoprecipitation of FLAG-ING4 was successful in
pulling down the ING4 complex.

32

Fig 6 ING4 complex purification from high salt nuclear extract.
A) ING4 complex purification scheme from nuclear extract dialysed to 300mM
KCl.
B) ING4 levels remain constant after high salt dialysis of nuclear extract.
(Western blot with indicated antibodies)
C) Silver stain of the high salt purified ING4 complex compared to a mock
purification.
D) High salt P11-M2 purification scheme of the ING4 complex.
E) Analysis of ING4 and HBO1 in the P11 eluted fractions. (Western blot of
eluted fractions denoted by number and elution buffer used with indicated
antibodies).
F) Silver stain of P11/M2 purified ING4 complex (ING4C). Proteins in each gel
slice (as indicated) were identified by mass spectrometry.
G) Verification of ING4 and HBO1 in the purified ING4C compared to a mock
purification. (Western blot with indicated antibodies)
H) Verification of MLL1 and associated proteins in ING4C. (Western blot with
indicated antibodies)
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2.2.3 Identification of BRPF1/2/3 as an additional subunit
In addition to bands corresponding to the proteins previously identified as
being members of the ING4 complex, a larger band of ~150kDa was also
observed in the silver stain (Fig 6F, slice 3). Mass spectrometry analysis
identified this as BRPF1/2/3 (BRPF2 is also known as BRD1), proteins that were
originally found to be members of the ING5 complex, but not the ING4 complex
(Table 1). However other members of the ING5 complex such as MOZ, MORF
and ING5 itself were not detected, suggesting a bona fide interaction between
BRPF1/2/3 and the ING4 complex rather than contamination by the ING5
complex. BRD1 was also found to be associated with ING4 by Mishima et al
(Mishima, et al., 2011), although the complex obtained there also contained
many other proteins such as HSP90, TR150 and hnRNPC1. In contrast, the
more stringently purified ING4 complex obtained here does not contain these
other proteins. This implies that BRPF1/2/3 interact more strongly with ING4 than
do these other proteins and suggests that BRPF1/2/3 are members of the core
ING4 complex.

2.2.4 Association with the MLL1 complex
The analysis by mass spectrometry identified several additional proteins
as MLL1, ASH2L, RBBP5, and WDR5 and CCAR1 (Fig 6F). The MLL1, ASH2L,
RBBP5 and WDR5 proteins were of interest as they comprise the core MLL1
complex, which is capable of H3K4 methylation (Dou, et al., 2006). These
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subunits were subsequently verified by Western blot (Fig 6H). While the
aforementioned MLL1 subunits could be identified by mass spectrometry
analysis and Western blot, unlike the other ING4 complex subunits they could not
be easily matched to any of the visible bands on the silver stain (Fig 6F). This
suggests that the MLL1 subunits are substoichiometrically associated ING4, and
are not an integral part of the ING4 complex, but rather exist as a separate MLL1
complex that interacts strongly with the ING4 complex.

2.3 Structure of the ING4 complex
2.3.1 JADE1L forms the central scaffolding protein for the ING4
complex and is stabilized by HBO1
To better understand the arrangement of subunits within the ING4
complex, a reconstitution of the complex was done using baculovirus to express
the desired proteins in Sf9 cells. For the purposes of this reconstitution (to
determine direct interactions between individual protein subunits), this system is
advantageous to using a mammalian system due to the risk of contamination
with the naturally interacting endogenous mammalian proteins that would be
present in a human cell line. Additionally, the reconstituted complexes were
analyzed by Coomassie stain, which would reveal the presence of any
contaminating Sf9 proteins that might be present in the final purification.
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First, the originally identified Jade1L-HBO1-ING4-hEAF6 complex (termed
JHIE) was reconstituted by infecting Sf9 cells with baculoviruses expressing
JADE1L, HBO1, hEAF6 and FLAG-ING4. The resulting protein complex was
purified by M2 affinity purification and Coomassie stained. This revealed bands
that corresponded to the expected subunits, indicating a successful reconstitution
of the JHIE complex (Fig 7A & 7B).

Different combinations of the baculoviruses were also used to provide
information regarding protein-protein interactions within the complex. Omission of
hEAF6 had minimal effects on the resulting complex. As expected, the hEAF6
subunit was absent but the remaining JADE1L, HBO1 and FLAG-ING4 subunits
were still present in the resulting complex at comparable levels. Omission of
JADE1L resulted in the complete loss of HBO1 as well as JADE1L, indicating
that HBO1’s association with the ING4 complex is through the JADE1L subunit.
Levels of hEAF6 was also reduced but not completely absent, indicating that the
hEAF6 subunit does bind directly to ING4, but that its presence in the complex is
stabilized either directly or indirectly by the presence of JADE1L.

Omission of HBO1 resulted in a significant but incomplete loss of JADE1L
in addition to the loss of HBO1, as well as a reduction in hEAF6 similar to what
was observed in the JADE1L omission (Fig 7C). This suggests that while HBO1
is a peripheral subunit, whose association with the complex is through JADE1L, it
38

Fig 7. Reconstitution and purification of ING4 complex subunits.
A) JHIE and BHIE complexes reconstituted by baculovirus expression in Sf9 cells
of JADE1L, HBO1, FLAG-tagged ING4, and hEAF6 or BRD1, HBO1, FLAGtagged ING4 and hEAF6 respectively. The resulting complexes were purified
through M2-affinity purification. (Coomassie stain)
B) Western blots of the reconstituted JHIE and BHIE complexes verifying the
identity of ING4, HBO1 and hEAF6. (Western blot with indicated antibodies)
C) ING4 pull-downs from Sf9 cells infected with baculoviruses combinations
expressing the indicated subunits. (Coomassie stain)
D) JADE1L and BRD1 are stabilized in the presence of HBO1. Purification of
reconstituted JADE1L, JADE1L-HBO1, BRD1 and BRD1-HBO1 through FLAGtagged JADE1L or FLAG-tagged BRD1. Note the increased levels of JADE1L
and BRD1 obtained when they are coexpressed with HBO1. The BRD1
reconstitutions were also subjected to Western blot to verify the identity of the
degraded BRD1. (Coomassie stain and Western blot with indicated antibody)
E) Purification of individual FLAG-ING4 and FLAG-HBO1 proteins via baculovirus
expression in Sf9 cells. (Coomassie stain)

39

Fig 7A

Fig 7B

Fig 7C

40

Fig 7D

Fig 7E

41

does play a role in stabilizing JADE1L. This stabilization has been previously
observed when both proteins were expressed in mammalian cells (Foy, et al.,
2008). The loss of hEAF6 could be due to a stabilizing effect by HBO1, but can
also be interpreted as a secondary effect, since the loss of JADE1L has already
been shown to adversely affect the integration of hEAF6 into the complex.

To further verify the HBO1-JADE1L interaction and stabilization, FLAGJADE1L was expressed either alone, or together with HBO1, and M2 affinity
purified (Fig 7D). As evidenced from the JADE1L-HBO1 dimer obtained, JADE1L
is capable of directly interacting with HBO1. Additionally, even though identical
titers of JADE1L expressing baculovirus were used in both cases, the amount of
JADE1L that was obtained in the JADE1L-HBO1 purification was substantially
greater than the amount of JADE1L purified alone, again supporting the
stabilization of JADE1L by HBO1.

2.3.2 BRPF2 (BRD1) is an alternative scaffold to JADE1L and is
stabilized by HBO1
Comparing the JADE1L-containing ING4 complex to the BRD1-containing
ING5 complex, certain similarities can be observed. They both contain hEAF6,
they both contain an ING protein and they both contain a MYST HAT (HBO1 in
the case of ING4 and MOZ/MORF in the case of ING5). The BRPF subunit is
known to function as the central scaffold for the ING5 complex, while the JADE
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subunit has been shown to function as the central scaffold for the ING4 complex.
Based on these similarities, it seemed possible that BRD1 might also play a
similar role in an ING4 complex by replacing JADE as the central scaffold.

The ability of BRD1 to interact directly with HBO1 was first established by
expressing and purifying either FLAG-BRD1 alone or together with HBO1 (Fig
7D). While expression of BRD1 on its own was minimal and heavily degraded,
the addition of HBO1 resulted in increased expression and stability of BRD1 (Fig
7D, western blot of BRD1), indicating that HBO1 has a stabilizing effect on BRD1
similar to what is observed with JADE1L. For comparison, FLAG-HBO1 and
FLAG-ING4 were also individually expressed and purified (Fig 7E).

A BRD1-HBO1-ING4-hEAF6 complex (termed BHIE) was then
reconstituted in the absence of any JADE (Fig 7A & 7B). The success of this
reconstitution indicates that a BRD1-ING4 complex could exist independently of
the JADE protein or the ING5 complex, and that BRD1 could substitute for JADE
as the central scaffold of the ING4 complex. This further suggests that the HeLa
purified ING4 complex, which contained both JADE1L/2/3 and BRPF1/2/3, is a
combination of two distinct complexes – one version that utilizes JADE as its
central unit, and another that utilizes BRPF, rather than one complex that
contains both JADE and BRPF (Fig 8).
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2.4 Discussion
In agreement with previous studies, the purification of an ING4 complex
verifies the presence of the originally identified JADE, HBO1 and hEAF6 subunits
(Doyon, et al., 2006), as well as the subsequently identified BRPF subunits
(Mishima, et al., 2011, Lalonde, et al., 2013). The absence of other proteins
previously identified by Mishima et al as being associated with ING4 such as
HSP90 or hnRNPC1, suggests that this more stringent purification contains
proteins that are more tightly associated with ING4. Additionally, the identification
of the MLL1 complex as a novel interacting partner of the ING4 complex
suggests a possible functional interaction between MLL1-mediated histone
methylation and ING4 complex activity.

From the reconstitutions of JHIE and BHIE complexes, it can be
concluded that two possible versions of the ING4 complex are possible-the
previously identified JHIE complex and the new BHIE complex. In contrast to
previous studies that used coimmunoprecipitation of overexpressed subunits
from human 293T cells with detection by Western blot (Saksouk, et al., 2009;
Lalonde, et al., 2013), the successful reconstitution of the complex in Sf9 cells in
the absence of other mammalian subunits strongly suggests that all the
interactions between member subunits are direct, that BRD1 is capable of
substituting for JADE as the central scaffolding subunit, and that the BHIE
complex is a version of the ING4 complex that can exist independently of JADE,
MOZ/MORF or any other protein.
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Fig 8. Schematic representations of the original JADE-ING4 and BRPF-ING5
complexes and the proposed BRPF-ING4 complex.
The originally identified ING4 complex consists of JADE, HBO1, ING4 and
hEAF6. The originally identified ING5-BRPF complex consists of BRPF,
MOZ/MORF, ING5 and hEAF6. Based on sequence homology, the presence of
BRPF (but not MOZ/MORF or ING5) in a purified ING4 complex suggests the
existence of a BRPF-HBO1-ING4-hEAF6 complex.
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While much progress has been made in identifying the key members of
the ING4 complex, as well as the various regions on the ING4 complex subunits
that are responsible for their interactions with one another, more work remains to
be done. The possibility of an ING4-ING4 or ING4-ING5 dimer raises the
possibility of an ING4 complex-ING4 complex or ING4 complex-ING5 complex
dimer (Palacios, et al., 2010), allowing for a whole array of permutations of
scaffolding and catalytic subunits, as well as an expansion of the number of
histone marks that can be read by such a dimer compared to a single ING4 or
ING5 complex. However the existence of such a dimeric complex and its effect
on chromatin has yet to be established.
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Chapter 3

Histone modifying activities of the
ING4 complexes
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3.1 Preface
In conjunction with ING4, HBO1 has been shown to acetylate H4
independent of trimethylated H3K4, while recognition of trimethylated H3K4 by
the ING4 PHD finger mediates acetylation of H3. (Saksouk, et al., 2009; Hung, et
al., 2009). The specific acetylated histone lysine residues that the ING4
complexes are responsible for seems dependent on the cell lines used. Its H4
HAT activity on nucleosomes is the same in 293T and MCF cells, where a
knockdown of HBO1 results in a global decrease of acetylation at H4K5, K8 and
K12 but not K16 (Doyon, et al., 2006). ChIP assays have linked overexpression
of various members of the ING4 complex to an increase in acetylation at H4K5,
K8, and K12 residues, as well as H3K9, K14 and K23 (Saksouk, et al., 2009;
Hung, et al., 2009; Avvakumov, et al., 2012; Mishima, et al., 2011; Lalonde, et
al., 2013).

In contrast, a knockout of HBO1 in a mouse primary embryonic fibroblast
cell line correlated only to a decrease in acetylation at H3K14, with acetylation at
H3K9 and H4K5 actually being increased while acetylation at H4K8 and H4K12
were unchanged (Kueh, et al., 2011). The actual sites which HBO1 is responsible
for acetylating may therefore vary between cell lines. Additionally, the limitation of
cell based assays are such that while the overall effects of protein
overexpression, knockdown or knockouts can be determined, there is no way to
tell if this is due to a direct effect of the ING4 complex itself, or is instead
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mediated indirectly through some other protein or protein complex. This
uncertainty is something that must be taken into account when trying to elucidate
the actual acetylation targets of the ING4 complex.

On an individual level HBO1 and ING4 have also been shown to interact
physically and directly with p53, although the direct ING4-p53 interaction appears
to be weak (Shiseki, et al., 2003; Zhang, et al., 2005; Palacios, et al., 2010).
Thus far however, these interactions have only been studied in isolation, looking
at each protein individually, rather than in the context of the ING4 complex.
Similarly, the effects of p53 have only been examined on immunoprecipitated
HBO1 HAT activity rather than in the context of a defined ING4 complex, and on
free histones rather than on the more physiologically relevant chromatin
substrate (Iizuka, et al., 2008).

To better identify the direct histone modifying activities of the ING4
complexes identified, we therefore aimed to set-up histone modifying assays in a
biochemically defined system using the previously purified and reconstituted
ING4 complexes. These assays would ultimately be performed on chromatin
which would also allow a direct examination of ING4 complex histone modifying
activity on a more physiological substrate. This would also allow any effects that
the JADE and BRPF subunits might have on the activity of the ING4 complex to
be elucidated. We also aimed to study ING4 complex activity in conjunction with
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p53 and trimethylated H3K4 to directly determine if these conditions, as previous
studies have suggested, would affect ING4 complex histone modifying activity.

3.2 The central scaffold subunit confers H3 or H4 HAT preference to the
ING4 complex HAT activity.
Using the purified endogenous ING4 ‘complex’ which contains both JADE
as well as BRPF (designated ING4C) as well as the reconstituted JHIE and BHIE
versions, we conducted HAT assays to analyze the catalytic capabilities. HAT
assays utilizing ING4C on recombinant histones and purified HeLa nucleosomes
show that ING4C acetylates free histones but that in the more restrictive and
physiologically relevant context of a nucleosomal substrate, acetylation is
restricted to histones H3 and H4, as has been previously reported (Doyon, et al.,
2006) (Fig 9A).

Next we examined the acetylation by the ING4 complex in the context of
chromatin. Chromatin was assembled using a p208ML p53 DNA template (Fig
9B), recombinant histones and the ACF/NAP1 system (An & Roeder, 2004) (Fig
9C). While ING4C was found to acetylate H3 and H4 equally well, the
reconstituted BHIE and JHIE complexes demonstrated a strong preference for
H3 and H4 acetylation respectively (Fig 9D). These observations further suggest
that the purified ING4C is actually a combination of JADE-based and BRPF
based-ING4-HBO1-hEAF6 complexes and that the net activity of ING4C is a
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Fig 9. HAT activity of the ING4 complex.
A) HAT activity of ING4C on 200ng of nucleosomes purified from HeLa cells or
200ng of individual recombinant histones using 3H radiolabeled acetyl-CoA.
ING4C acetylates free histones, but is restricted to H3 and H4 in the context of
nucleosomes. (Autoradiograph shows incorporation of 3H into
nucleosomes/histones. Coomassie stain of the corresponding substrates used is
included as a loading control).
B) p208ML p53 DNA template containing five p53 response elements used to
assemble chromatin.
C) Chromatin assembly and HAT assay outline. The DNA template, purified
chromatin assembly factors and recombinant histone octamers were incubated
for 3 hours at 27’C to assemble the chromatin. p53 was added and incubated for
a further 20 minutes at 27’C to allow binding to the p53 binding sites present on
the DNA. Finally the HAT of interest and acetyl-CoA was added and incubated at
30’C to allow the histone acetylation reaction to occur.
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Fig 9. (continued)
D) ING4 complex HAT assay on chromatin. ING4C acetylates H3 and H4 in the
context of chromatin, while JHIE preferentially acetylates H4 and BHIE
preferentially acetylates H3. p53 has no detectable effect on HAT activity.
(Autoradiograph)
E) Time course of ING4C acetylation of chromatin using low levels of ING4C .
No detectable p53 effect on ING4C acetylation. (Autoradiograph)
F) JHIE/BHIE HAT assay on chromatin. A very slight p53 dependent signal can
be observed with a long exposure. (Western blot with indicated antibody. The top
row is a short exposure of the blot for two minutes while the bottom row is a
longer exposure of the blot for thirty minutes)
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combination of JHIE (acetylating H4) and BHIE (acetylating H3) HAT activity.
These observations also reveal a control over ING4 complex HAT specificity that
is mediated by the central subunit (either JADE1L or BRD1) similar to what has
been shown with the ING5 complex (Lalonde, et al., 2013).

3.3 H3 acetylation by the ING4 complex is enhanced by trimethylated H3K4
As a link between trimethylated H3K4 and ING4 mediated HAT activity
has been observed, we next investigated the effect of H3K4me3 on the HAT
activity of our ING4 complexes. In agreement with previously reported results,
ING4C HAT activity on H3 peptides bearing the various K4 methylation states
was increased when H3K4 was di- or trimethylated (Fig 10A) (Saksouk, et al.,
2009; Hung, et al., 2009).

We further showed that this H3K4me3-dependent increase in H3
acetylation also occurred in the context of chromatin via HAT assays on
reconstituted chromatin. Chromatin was assembled with recombinant histones
using either H3 that was unmodified at K4 or that bore the methyl-lysine
analogue of trimethylated K4 (Lauberth, et al., 2013). Using equivalent amounts
of chromatin (Fig 10B), some increase in H3 acetylation in the presence of
trimethylated H3 could be detected with ING4C (Fig 10C). This increase can be
seen more clearly in the case of Western blots done against individual acetyl-
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Fig 10. H3K4me3-dependent ING4 complex HAT activity.
A) 3H-labeled acetyl-CoA HAT assay on H3 peptides containing the N-terminal 121 residues of H3 with different K4 methylation states provided by the
Rockefeller University Proteomics Center. Counts per minute of each sample
was assayed with scintillation. Results are from two independent experiments for
me0 and me1 and three independent experiments for me2 and me3. Error bars
indicate the standard deviation.
B) H3K4me0 and H3K4me3 analog chromatin assemblies (chrom) used in
subsequent assays. (Coomassie stain)
C) HAT assay on chromatin assembled with recombinant unmodified histones or
with histones with the H3K4me3 analog. A slight increase in activity is observed
in the presence of H3K4me3. (Autoradiograph)
D) Acetylation on H3K18 and H3K9 after chromatin acetylation by ING4C, JHIE
and BHIE. ING4C. ING4C acetylation of H3K9 and BHIE acetylation of H3K9 and
H3K18 is enhanced by H3K4me3. (Western blot. The top four rows are short, two
minute exposures of the blots while the bottom four rows are longer, thirty minute
exposures of the same blots)
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lysines. These blots revealed that acetylation of H3K9 by ING4C and H3K9 and
H3K18 by BHIE, but not by JHIE, was increased in the presence of trimethylated
H3K4 (Fig 10D). This is consistent with the observation that BRD1 mediates
HBO1 H3 HAT specificity, while JADE1L mediates HBO1 H4 HAT specificity.
Western blots were also conducted for H3K14 acetylation, but no signal was
detected (data not shown).

3.4 Interaction with p53
3.4.1 ING4 and the ING4 complex are capable of direct physical
interactions with p53
ING4 has been shown to physically associate with p53 in the cell,
although the assays in these cases have consistently used ectopically
overexpressed ING4 (Shiseki, et al., 2003; Zhang, et al., 2005). To verify that the
physical association is something that occurs normally with natural levels of
ING4, endogenous ING4 was immunoprecipitated from doxorubicin treated
HCT116 cells that contain functional p53. p53 was found to coIP with ING4 (Fig
11A). These results are consistent with, but do not prove, a direct interaction
since the contribution of other proteins to this association have not been ruled
out.

In vitro, a direct interaction has also been mapped out between purified
p53 and ING4, although not in the context of the ING4 complex (Zhang, et al.,
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2005). To verify that this interaction can also take place in the context of the
more physiologically relevant ING4 complex, binding assays were conducted
with bacterially purified GST-p53 and the ING4 complex as well as with purified
ING4 on its own (Fig 11B). These combined results showed that p53 can directly
bind both to ING4 as isolated subunit and also to the ING4 complex as a whole.

Interactions between HBO1 and p53 have also been noted and were
verified in vitro using purified components. In fact, every subunit of the ING4
complex that was tested in an in vitro binding assay was observed to interact
directly with p53 despite stringent wash conditions (Fig 11B). This begs the
question of whether any of these p53 interactions are actually valid associations
that occur in vivo, rather than non-specific interactions to some especially
tractable region of p53. Regardless, these assays show that both ING4 as well
as the ING4 complex is capable of binding directly to p53, at least under the
conditions used in the in vitro assays both here and in the literature.

3.4.2 p53 does not directly affect ING4 complex HAT activity on
chromatin
It has been shown that p300, another p53 cofactor that is a histone
acetyltransferase and interacts with p53, is capable of increased acetylation of
H3 and H4 in the context of chromatin in the presence of p53. In fact, while p300
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Fig 11. ING4 complex interacts with p53.
A) p53 coIPs with ING4. Endogeneous ING4 IP from HCT 116 cells treated with
doxorubicin. p53 association analyzed by Western blot.
B) In vitro binding using purified ING4 complex subunits and GST-p53. Binding to
p53 was analyzed by Western blots against the FLAG-tagged subunit.
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is able to acetylate free histones or nucleosomal substrates on its own, its ability
to acetylate chromatin is almost completely dependent on the presence of an
activator such as p53 (Espinosa & Emerson, 2001; An, et al., 2004). In light of
this p53-dependent activity by a p53-associated histone acetyltransferase, it
seemed possible that the ING4 complex, interacting with p53 and containing a
histone acetyltransferase, might also have a p53 affected/dependent chromatin
acetylation.

To test this hypothesis, an ING4 complex HAT assay was carried out
using chromatin assembled from recombinant histone octamers and purified
factors. While, as previously observed in the literature, p300 acetylation of
chromatin was strongly dependent on the presence of p53, histone acetylation by
the ING4 complex seemed to be completely independent of p53, being equally
strong in the presence of or absence of p53 (Fig 9D). Moreover, no p53 effect
was observed even when lower amounts of the complex were used in a kinetic
acetylation assay (Fig 9E compare lanes 9 with 10, and 11 with 12), which has
been previously used to elucidate an activator-dependent histone acetylation on
a similarly promiscuous HAT (Ikeda, et al., 1999). This p53 independence
contrasts sharply with p300 mediated chromatin acetylation, which is strongly
dependent on p53 (Fig 9E lanes 1 and 2). An extremely small effect can possibly
be observed at H3K18 if the Western blot is exposed for an extended period of
time, but this effect is so slight as to be negligible (Fig 9F compare lanes 4 with 5
for JHIE and lanes 6 with 7 for BHIE). For comparison, the strong p53-dependent
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p300 acetylation of these residues is also shown here (Fig 9F compare lanes 2
and 3).

Therefore, despite the potential direct physical interaction capable of
forming between the ING4 complex and p53, the observed acetylation of
chromatin by the ING4 complex under these assay conditions does not require
and is not measurably influenced by the presence of p53. This is in contrast with
a previous study that reported an inhibition of HBO1 HAT activity by p53 in vitro.
However, as previously noted, that study used a crude HBO1 immunoprecipitate
rather than purified ING4 complex and studied its effects on free histones rather
than the more physiologically relevant chromatin substrate (Iizuka, et al., 2008).

3.4.3 A synergistic p300-BHIE HAT activity that is dependent on p53
Cooperative effects have been observed between various p53 cofactors,
such as p300 with PRMT1 and CARM1 (An, et al., 2004), MLL1 with MOF (Dou,
et al., 2005), and p300 with SET1 (Tang, et al., 2013). Since both p300
(Espinosa & Emerson, 2001; An, et al., 2004) and ING4 (Shiseki, et al., 2003;
Zhang, et al., 2004; Doyon, et al., 2006) have been implicated in p53-dependent
transcription from p21 or a p21 promoter it seemed possible that both proteins
might work together. An attempt was thus made to see if there a cooperative
HAT effect might be observed by combining the two activities together.
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To this end a HAT assay on chromatin was conducted using p300 and the
JHIE and BHIE versions of the ING4 complex. Levels of p300 had to be
substantially decreased from what is usually used in p300 HAT assays as the
robust p300 acetylation of chromatin could be expected to mask any additional
effect from the ING4 complexes that might be seen. Levels of JHIE and BHIE
were also titrated to determine optimal conditions (data not shown). Under these
conditions an increased histone acetylation was observed, with greater H3K9
and H3K18 acetylation levels being observed when p300, JHIE and BHIE were
used together (Fig 12A lane 15), compared to when either was used individually
(Fig 12A lanes 3, 5 and 10). This effect is not simply a sum of the independent
HAT activities since acetylation by JHIE and BHIE alone under these conditions
is negligible, but rather a synergistic effect of their respective HAT activities.

To further investigate this synergistic effect, the assay was also done
using JHIE or BHIE individually in combination with p300. The greatest HAT
synergy was observed with when both p300 and BHIE were used together (Fig
12A compare lane 14 with 13). This is consistent with earlier observations
regarding the HAT specificity of BHIE and suggested that BHIE HAT activity
might be enhanced by p300. Moreover, this HAT synergy by p300 and BHIE is
strongly dependent on p53 (Fig 12A lanes 12 & 15), as is p300 HAT activity (Fig
12A lanes 2 & 3), whereas, as shown earlier, BHIE HAT activity on its own is not
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Fig 12. Cooperative p300 and ING4 complex HAT activity on chromatin.
A) A p53-dependent p300-ING4 complex HAT synergy on both H3K4me0 and
H3K4me3 containing chromatin. (Western blot with the indicated antibodies)
B) Scheme for ordering the p300 and BHIE acetylation on chromatin.
C) Ordered reactions of p300 and BHIE. p300 or BHIE or both were added to the
reaction as indicated to obtain sequential, simultaneous or individual acetylation
by p300 and/or BHIE. Maximal synergy is obtained with p300 followed by BHIE
acetylation. (Western blot with indicated antibodies)
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p53-dependent (Fig 9D, compare lanes 17 & 18 with 19 & 20). A comparative
analysis with templates assembled with H3K4me3 revealed no additional effect
of trimethylated H3K4 (Fig 12A, compare H3K4me0 with H3K4me3 rows),
suggesting that this synergy is not enhanced by the ING4 PHD fingertrimethylated H3K4 interaction.

One possible explanation for the p300-BHIE HAT synergy is that some
level of histone acetylation by p300 might be a prerequisite for maximal BHIE
HAT activity. If this were the case, the synergistic effect would be most
noticeable if the HAT reaction were ordered, with p300 histone acetylation taking
place first, followed by BHIE histone acetylation. To test this, the HAT reaction by
p300 and BHIE was staggered, with one HAT added before the other (Fig 12B).
As predicted, a p300 addition followed by BHIE addition showed the greatest
synergy (Fig 12C lane 9), compared to BHIE followed by p300 (Fig 12B lane 11),
BHIE and p300 added simultaneously (Fig 12C lane 13), or either p300 or BHIE
added individually (Fig 12C lanes 3 & 7). As before, this activity was strongly
dependent on p53 (Fig 12C lanes 8 & 9). Note that use of higher concentrations
of p300 does mask this synergistic effect (Fig 12C compare lanes 4 & 5 with lane
9), again emphasizing the need to avoid p300 saturation of the system.
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3.5 Synergistic MLL1 complex-ING4 complex activity
Having established that the core MLL1 complex was also present in the
purified ING4 complex, the next question was if the MLL1 complex was
catalytically active. A lysine methylation assay utilizing the ING4 complex-MLL1
complex purified from HeLa cells were therefore conducted on chromatin
assembled with recombinant histones. This assay determined that the MLL1
complex was indeed catalytically active, being capable of monomethylating, but
not trimethylating H3K4, as has been previously reported for this complex (Fig
13B lane 6) (Tang, et al., 2013).

Acetylation and methylation reactions require acetyl-CoA and SAM
respectively as cofactors. By controlling when/if these cofactors are added to the
reaction, the ability of the ING4 complex-MLL1 complex to acetylate or methylate
histones can be ordered or restricted and the effects of the histone acetylation on
H3K4 methylation and vice versa can be examined (Fig 13A). So, for example,
incubating the complexes with SAM for a time period, and then adding acetylCoA for a subsequent time period would result in methylation occuring first,
followed by acetylation. From this assay, as would be expected, addition of
acetyl-CoA resulted in H3 and H4 acetylation (Fig 13B lanes 2-5). However,
addition of acetyl-CoA also led to an increase in monomethylation of H3K4 when
added together with SAM, compared with SAM alone (Fig 13B compare lanes 24 with 6). This increase was greatest when acetyl-CoA was added
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Fig 13. H3K4 methylation of the MLL1 complex associated with ING4.
A) Scheme for ordering the methyltransferase and acetyltransferase of the ING4
complex and associated MLL1 complex present in ING4C. The order of the
methylation and acetylation is determined by controlling when the appropriate
substrate is added in – 3H labelled acetyl-coA for acetylation and S-adenosyl
methione (SAM) for methylation.
B) ING4C-MLL1C HAT/KMT assay on chromatin. (Western blots with indicated
antibodies to determine methylation and autoradiography to determine
acetylation)
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simultaneously with SAM (Fig 13B lane 4). Conversely, addition of SAM had no
significant effect on histone acetylation, regardless of the order of the reactions
(Fig 13B compare lanes 2-4 with 5). To see if this enhancement could be
enhanced by further histone acetylation, p300 and the p53 required for p300
chromatin acetylation were added, but no further increase in K4 methylation was
observed (Fig 13B lane 1). Therefore the ING4 complex HAT activity enhances
MLL1 complex mediated H3K4 methylation, similar to what has been seen
between p300 and SET1 complex H3K4 methylation (Tang, et al., 2013).

3.6 Discussion
From this study we can conclude that the primary determinant of histone
acetylation specificity in the ING4 complex is the choice of the scaffold subunit
that holds the complex together. A BRD1 complex preferentially acetylates H3
while a JHIE complex preferentially acetylates H4, similar to what has been
shown for the ING5 complex (Lalonde, et al., 2013). In contrast, purified ING4C,
which contains both JADE and BRPF proteins, acetylates both H3 and H4
equally. This is consistent with the hypothesis that the activity of the purified
ING4C is in fact a combination of the activities of two distinct ING4 complexes.

Using chromatin assembled with recombinant histones and purified
factors, the HAT assays with both ING4C and the recombinant JHIE and BHIE
have verified that H3 acetylation is increased by trimethylated H3K4. These
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assays further identify H3K9 and H3K18 as two of the residues where this
increase in acetylation takes place, and further establish H3K18 as an ING4C
and BHIE acetylation target. More specifically, these assays show that this
trimethylated H3K4-dependent activity occurs with BHIE and with ING4C (which
we hypothesize contains the BRPF version as well as the JHIE version of the
ING4 complex) but not with JHIE.

While other groups have linked the JADE-containing ING4 complex to a
trimethylated H3K4-dependent increase in H3 acetylation (Hung, et al., 2009;
Saksouk, et al., 2009; Avvakumov, et al., 2012), those links were made based on
ChIP assays or ING4 complexes whose precise composition remains unclear. In
the former case, while ChIP assays can show an increase in a histone mark in
response to an increase in JADE, the limitations of cell-based assays mean that
there is no way to tell if the effect is a direct one. In the latter case, possible
contamination with the BRPF-based ING4 complex means that the H3
acetylation may not be due to the JADE-containing ING4 complex at all, but
rather by a BRPF-containing ING4 complex.

The acetylation of H3K14 has also been linked to the ING4 complex
through overexpression, knockdowns and knockouts of various ING4 complex
members (Saksouk, et al., 2009; Kueh, et al., 2011; Mishima, et al., 2011).
However, in contrast to this in vivo correlation, our in vitro HAT assays using
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purified ING4 complexes and chromatin assembled with recombinant naïve
(unmodified) histones failed to show any H3K14 acetylation under any of the
conditions examined (p53, p300, trimethylated H3K4). H3K14 acetylation may
therefore not be a direct target of the ING4 complex, but could instead be a
subsequent downstream effect of ING4 complex activity. For example, a
subsequent recruitment of MOZ/MORF, which has been shown to acetylate
H3K14 (Doyon, et al., 2006), could account for such a link between the ING4
complex and H3K14 acetylation. Alternatively, given the number of chromatin
recognizing domains present in the ING4 complex, it is possible that there is a
histone mark missing from the naïve chromatin used here that is a prerequisite
for H3K14 acetylation by the ING4 complex.

ING4 effects on cell growth and activation of p53 target genes is
dependent on p53 (Shiseki, et al., 2003; Zhang, et al., 2004) and a direct
physical interaction between p53 and components of the ING4 complex has been
shown in this study and elsewhere (Zhang, et al., 2005, Iizuka, et al., 2008).
However no direct p53-dependent effect on ING4 complex histone acetylation of
any significance was observed in any of the in vitro HAT assays. What then
accounts for the ING4 dependency on p53 that is observed in cells? One
pathway by which this might be accomplished is through the establishment of
trimethylated H3K4 via the SET1 complex, a pathway that has been shown
elsewhere to be p53-dependent (Tang, et al., 2013). Another pathway is the one
that has been established here, through ING4 complex synergy with p300 (Fig
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14). So while there is no direct effect of p53 on ING4 complex HAT activity, there
are at least two indirect pathways by which a p53 effect on ING4 complex activity
is apparent. Future studies involving the integration of all of these pathways
might further uncover additional mechanisms by which p53 affects ING4 complex
activity.

Lastly we have described here a novel interaction between the ING4
complex and the MLL1 complex and shown that ING4 complex activity is capable
of enhancing H3K4 monomethylation by the MLL1 complex. However the
functional role of this H3K4 monomethylation in the context of ING4 complex
activity is unclear. It could be a precursor to H3K4 di- or trimethylation, leading in
turn to additional ING4 complex H3 acetylation in a feed-forward loop, or it could
act as a mark that serves to recruit some other protein or protein complex. These
are two possible avenues of further investigation, although both would require the
identification and incorporation of additional interacting factors.
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Chapter 4

Mediation of transcription by the
ING4 complex
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4.1 Preface
Members of the ING4 complex have been linked to transcriptional activity
in various ways. As mentioned previously, overexpression of ING4 leads to
activation of p21 and BAX genes in a p53-dependent manner (Shiseki, et al.,
2003; Zhang, et al., 2004) and overexpression of HBO1 was found to have a
similar effect (Avvakumov, et al., 2012). Knockdowns of HBO1 in 293T cells
decrease overall levels of H4K5, K8 and K12 acetylation (Doyon, et al., 2006)
while knockouts of HBO1 and BRD1 in mice lead to a depression of
transcriptional activity of various genes and an overall decrease in H3K14
acetylation (Kueh, et al., 2011; Mishima, et al., 2011).

ING4 and its complex members have been further linked to transcription
activity by establishing their presence on genes via ChIP assays. Ectopically
expressed ING4, JADE1L, BRD1 and HBO1 have been shown to localize around
the TSS of genes, to colocalize with various histone modifications, and to
correlate with actively transcribed genes. ING4 colocalizes with acetylated H3K9
and trimethylated H3K4 on SMC4 (Hung, et al., 2009) while JADE1L was shown
to colocalize with trimethylated H3K4 and acetylated H3K14 and H4K8 at the
TSS of EXT1 and FOXP4 as well as further down the body of the genes where it
colocalized instead with trimethylated H3K36 (Saksouk, et al., 2009). The
catalytic subunit HBO1 tends to colocalize with BRD1 on genes that are
transcriptionally active (Mishima, et al., 2011) and correlates with acetylated
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H3K14 on the coding region of genes (Kueh, et al., 2011). Altogether these
results suggest that ING4 and its complex members correlate with transcription
and transcriptionally associated histone acetylation.

With regard to p53-associated transcription, endogenous HBO1, BRD1
and its BRPF1 paralog, as well as the ING5 protein, have been shown to bind to
the region around the TSS of the p53 target p21 gene (Avvakumov, et al., 2012;
Lalonde, et al., 2013). Taken together with the more general links made between
ING4 complex subunits and transcriptional activation as well as the observed link
between ING4 and p21 expression, these results suggest that ING4 and ING4
complex subunits could potentially act in conjunction with p53 to activate a p53
target gene.

Caution, however, must be taken in the extrapolation of these results to
the ING4 complex. While JADE1L, HBO1 and BRD1 are members of the ING4
complex, they are not found exclusively in the ING4 complex. So while results
involving these proteins can tentatively suggest ING4 complex enrichment and
activity, the only protein that can be used to conclusively extrapolate ING4
complex enrichment and activity is ING4 itself. Additionally, the use of ectopically
overexpressed proteins in the ChIP assays may not reflect the enrichment that
occurs normally with the endogenous protein. Finally, previous ING4 and ING4
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complex subunit ChIPs that have looked at p21 occupancy have only looked at
occupancy on p21 in the absence of p53 activation.

Therefore the first thing we aimed to do was to study the enrichment of
endogenous ING4 (and thus the ING4 complex) on a p53 target gene and to
correlate this with p53-dependent gene activation. We then planned to
complement these cell-based correlations by directly investigating the
contribution of the ING4 complex to transcription in the context of a p53dependent in vitro transcription system from chromatin templates. Guided by our
histone modification studies, we would then use this system to look at conditions
that affect the ING4 complex histone modifying activity to see if these might be
translated into an effect on transcription.

4.2 ING4 enrichment on p21
4.2.1 ING4 recruitment to p21 correlates with gene activation
To better determine the activity of the ING4 complex in association with
transcription under endogenous protein conditions, ING4 ChIP assays were
conducted against endogenous ING4 in HCT116 cells (which contain wild type
p53) that had been with treated with the DNA damaging reagent doxorubicin in
order to activate transcription of p53 target genes. The enrichment of ING4
around the TSS of p21 (where HBO1, BRPF1/2 and ING5 have previously been
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shown to localize (Avvakumov, et al., 2012; Lalonde, et al., 2013) was
subsequently examined by quantitative PCR.

Under conditions of doxorubicin treatment, ING4 was enriched at the p21
TSS and the region immediately downstream compared with untreated cells (Fig
14B). This enrichment was further accompanied by an increase in acetylated
H3K9 (Fig 14C). As this region is also enriched with trimethylated H3K4 (Tang, et
al., 2013), ING4 occupancy on p21 correlates with trimethylated H3K4 (which is
recognized by the ING4 PHD finger), acetylated H3K9 (which is acetylated by
HBO1 in the ING4 complex), and p53 gene activation. This is consistent with the
results of the in vitro HAT assays, which show that the ING4 complex binds to
trimethylated H3K4 and acetylates H3K9.

4.2.2 ING4 recruitment to p21 is dependent on p53
While p53 has no direct effect on ING4 complex chromatin acetylation in
vitro, this study has shown than an indirect p53-dependent effect does exist. It is
thus possible that p53 would also have an indirect effect on recruitment and
histone acetylation of ING4 on p21 in the cell. To investigate this possibility, an
ING4 ChIP was conducted on HCT116 p53 knockout (p53 -/-) cells. As can be
seen, the absence of p53 caused a substantial reduction in occupancy of ING4
on p21 compared to the p53-containing HCT116 cells (Fig 14D). The increase in
levels of acetylated H3K9 from the untreated to the treated cells were also

82

Fig 14. ING4 enrichment around the p21 transcription start site (TSS)
correlates with gene activation by p53 and correlates with increased
H3K9ac enrichment.
A) Diagram of p21 gene with location of sites targeted by ChIP primers indicated
by arrows. Sites were selected based on observations that members of the ING4
complex tend to localize to the area immediately around the TSS. (Red line: TSS.
p53 RE: p53 response element. The ladder shows the distance in Kb from the
TSS)
B-E) ChIP assays on HCT 116 cells treated and untreated with doxorubicin.
Results are from two independent assays. Error bars show the standard error.
(con: control (untreated) cells. dox: cells treated with 0.5mM doxorubicin for 4
hours. p53 -/-: p53 knockout cell line.)
B) Doxorubicin treatment causes an increase in ING4 enrichment at the TSS and
immediately downstream of the TSS of p21 compared to control cells.
C) Doxorubicin treatment causes an increase in H3K9ac enrichment that
correlates with ING4 enrichment compared to control cells.
D) In the absence of p53, ING4 enrichment upon doxorubicin treatment is
decreased compared to control cells.
E) In the absence of p53, H3K9ac enrichment upon doxorubicin treatment is
decreased compared to control cells.
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reduced (Fig 14E), which is what would be predicted if such acetylation were due
to the ING4 complex. Thus, in the cell the recruitment of ING4 to p21 is
dependent on p53, as is the enrichment of H3K9 acetylation upon doxorubicin
treatment.

4.3 p53-dependent, ING4 complex-mediated in vitro transcription
The described cell-based assays have provided clues as to the activity of
the ING4 complex with respect to transcription in general and p53-mediated
transcription in particular. However, the recurring limitation with such cell-based
assays is that they are unable to show a direct causative effect of the ING4
complex on the transcriptional activation of target genes (p53 or otherwise). This
difficulty is compounded by the multiple roles that ING4 and its complex are
suspected to play in the cell. In addition to its role in p53-dependent gene
activation, ING4 has also been implicated in the repression of NF-κB and HIF-1α
pathways (Coles & Jones, 2009), while HBO1 plays a vital role in DNA replication
(Burke, et al., 2001) and regulation of genes involved in erythropoiesis and
embryonic patterning (Mishima, et al., 2011; Kueh, et al., 2011). The multiplicity
of possible ING4 complex effects in the cell thus makes it difficult to elucidate
ING4’s precise role in p53 mediated transcription in such as system.
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The strategy used here to resolve this dilemma is to study the effects of
the ING4 complex in conjunction with p53 via an in vitro chromatin transcription
system (Fig 15A). The use of such an in vitro system allows for the elimination of
extraneous variables and indirect effects of the ING4 complex on p53-mediated
transcription by changes in the expression of other genes or effects on DNA
replication and the cell cycle. This allows for more focused conclusions on the
ING4 complex’ direct effects on p53-mediated transcription to be drawn.

4.3.1 The ING4 complex has a direct effect on p53-mediated
transcription from chromatin templates
In vitro transcription assays on chromatin showed that while p53 alone
had a minimal effect (Fig 15B lane 2), addition of the ING4C with p53
substantially enhanced transcription to a level comparable to what is seen with
p300 (Fig 15B lanes 3 & 4). This demonstrates that ING4C does indeed function
directly to enhance p53-mediated transcription and that ING4, in the context of its
complex, does function as a transcriptional coactivator for p53. This effect was
also observed using both of the reconstituted JHIE and BHIE. While JHIE or
BHIE alone resulted in some p53-dependent transcription, transcription levels
increased when both were used together (Fig 15C). Note, however, that this
required titration of proteins since higher concentrations of JHIE and BHIE inhibit
transcriptional activity (Fig 15D). This suggests that both the JADE and BRD
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Fig 15. ING4 complex effects on p53-mediated transcription from chromatin
templates.
A) Outline of in vitro transcription assay from chromatin templates.
B) ING4C enhances p53-dependent transcription on chromatin templates. 30ng
of p300 and 20ng of ING4C were used.
C) JHIE and BHIE cooperate to enhance p53-dependent transcription. 7.5 ng of
JHIE and 6ng of BHIE were used.
D) Excess JHIE and BHIE inhibit transcription. JHIE titration is from 15-60ng.
BHIE titration is from 15-120ng.
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versions of the ING4 complex are required for optimal HBO1/ING4-based p53
coactivator functions, and that JHIE and BHIE are both required to properly
reconstitute purified ING4C activity.

Previous work has established the importance of joint H3 and H4
acetylation by p300 for p53-dependent transcription from chromatin (An, et al.,
2004). In the in vitro transcription assays done here however, the addition of
ING4C or JHIE and BHIE in the absence of p300 is sufficient to allow p53dependent transcription. This suggests that it is the HAT activity of the ING4
complex that is important for its effect on chromatin transcription, and that the H3
and H4 acetylation supplied by ING4C or jointly by JHIE and BHIE is sufficient to
allow this transcription. The fact that JHIE, which gives predominantly H4
acetylation, and BHIE, which gives mostly H3 acetylation, resulted in less
transcription on their own than together supports the importance of both H3 and
H4 acetylation for transcription from chromatin (Fig 15C).

4.3.2 ING4 complex-mediated transcription activity is enhanced by
trimethylated H3K4
Having established that trimethylated H3K4 has a positive effect on
ING4C and BHIE HAT activity, it seemed possible that this could also translate to
a trimethylated H3K4-dependent effect on ING4C transcriptional activity. To
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investigate this possibility, in vitro transcription assays were conducted with
chromatin templates assembled with the trimethylated H3K4 analogue (Simon, et
al., 2007) and carried out in conjunction with p300. As before, levels of p300 had
to be titrated down to prevent masking of any ING4 complex contributions.
ING4C used was similarly titrated to determine optimal concentrations (data not
shown).

Under these conditions with reduced levels of p300, the presence of
trimethylated H3K4 was crucial to ING4C-dependent as well as p300-dependent
p53-mediated transcription (Fig 16A lane 4). This activity was dependent on p53
and acetyl-CoA, with no significant transcriptional activity observed in the
absence of p53 or acetyl-CoA (Fig 16A compare lanes 4 with 7 & 9). The p53dependency is consistent with ING4’s role as a p53 coactivator rather than as an
independent transcription activator of its own. The acetyl-CoA dependency
further suggests that it is the ING4C HAT activity that is responsible for its
contribution to transcription. As with the reconstituted JHIE and BHIE, the
amount of ING4C used here is critical, as too much of it seems to inhibit
transcriptional activity (Fig 16A compare lanes 4 & 5).
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4.3.3 ING4 complex-mediated transcription activity is enhanced by
p300
The synergy previously noted between p300 and the ING4 complex HAT
activity, and the established link between histone acetylation and transcription,
suggested the possibility of transcriptional synergy between p300 and the ING4
complexes. In fact addition of both p300 and ING4C resulted in a slight increase
in transcriptional activity (Fig 16A compare lanes 3 & 4 with 6). As the HAT
synergy between p300 and the ING4 complex was most apparent when they
were added sequentially to the reaction, the in vitro transcription assay was
similarly modified so that p300 was allowed to acetylate chromatin prior to the
addition of JHIE and BHIE (Fig 16B). This ordered reaction, as with the HAT
activity, gave greater levels of transcription than either p300 or JHIE and BHIE
alone (Fig 16C lanes 4, 5, 7 & 8) and is dependent on p53 (Fig 16C lanes 8 & 9).
This correlation between HAT synergy and transcription synergy further supports
the link between histone acetylation and transcription.

This cooperative effect between p300 and the ING4 complex also allows
lower levels of p300 to be used than is normally required to see the p53dependent transcription in the p300 only system. So while it is possible to
overcome the lack of other HATs by using an excess of p300, the inclusion of the
JHIE and BHIE, which reflects the more physiological condition found in the cell
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Fig 16. Factors that enhance ING4 complex histone acetylation enhance
ING4 complex-mediated p53-dependent transcription.
A) In vitro transcription assay on chromatin comparing chromatin incorporating
naïve (unmodified) histone octamers and chromatin incorporating the H3K4me3
analogue, with reduced levels of p300 (12.5ng) and ING4C (6 or 12ng).
B) Outline for of in vitro transcription assay with sequential p300 and JHIE/BHIE
histone modification.
C) In vitro transcription assay on chromatin modified by p300 or JHIE/BHIE
individually, or sequentially by p300 then by JHIE/BHIE. 12.5ng of p300 was
used with 7.5 or 15ng of JHIE and 6 or 12ng of BHIE.
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Fig 16A

Fig 16B

Fig 16C
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where all these HATs are present, allows transcriptional activity to be obtained
with ~3 fold lower concentration of p300.

4.4 Discussion
The ChIP assays conducted here show that endogenous ING4 enrichment
on the p21 promoter is enhanced upon activation of the p21 gene. This is
consistent with the hypothesized role of ING4 and ING4C in the activation of
genes. In keeping with what is known about ING4C histone acetylation activity,
this enrichment is correlated with trimethylated H3K4 and H3K9 acetylation. This
is what would be expected if ING4C were mediating transcription by recognizing
trimethylated H3K4 and acetylating histones. Furthermore, by using a p53
knockout cell line, this study establishes that the association of ING4 and
acetylated H3K9 on the p21 TSS in response to doxorubicin treatment is
dependent on p53.

Note that while these assays show the p53 dependency of ING4
recruitment to p21, it does not mean that this dependency is direct. In fact the
data available suggest that ING4 is recruited primarily to the TSS of p21 rather
than the p53 response elements (Avvakumov, et al., 2012; Lalonde, et al., 2013).
This is a different enrichment pattern from p300, which is recruited to the p53
response elements (Dr Wei Yi Chen, Rockefeller University, unpublished data).
The recruitment of p300 and the ING4 complex to different regions of p21 may
95

be indicative of the different pathways by which they are recruited by p53. p300
is directly recruited by p53 and colocalizes with p53 at the p53 response
elements upon gene activation. In contrast, the HAT activity of the ING4
complexes is not directly dependent on p53, and ING4 is not recruited to the p53
response elements. Rather, it is recruited to the TSS where it colocalizes instead
with trimethylated H3K4.

Having established that ING4 is indeed associated with a p53 target gene
under conditions of gene activation and that this association is dependent on
p53, we then turned to an in vitro approach in order to overcome the limitations of
cell-based assays. In contrast to all previously conducted assays associating the
ING4 complexes with transcription, the in vitro transcription system established
here demonstrates conclusively the direct effect of the ING4 complexes on p53mediated transcription. This directly demonstrates its role as a transcriptional
coactivator of p53. Furthermore it shows that in the context of this transcription
system, in the absence of p300, ING4 complex activity is necessary for p53mediated transcription and that this activity only occurs when acetyl-CoA, a
necessary cofactor for acetylation is present. Lastly it shows that ING4 complex
activity is capable of supporting p53-mediated transcription without any other
ectopically added HATs, with the caveat that contributions from endogenous
proteins in the nuclear extract used for the transcription cannot be ruled out.
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In conjunction with what is known about the requirements for p300 H3 and
H4 acetylation from the transcription assays done elsewhere using p300 and p53
(An, et al., 2004), and the known H3 and H4 acetylation specificity of the ING4
complexes, the logical conclusion would be that in this ING4 complex-dependent
p300 independent system, the necessary H3 and H4 acetylation is being
supplied by the ING4 complex. This is further corroborated by the fact that
transcription attempted with the reconstituted JHIE or BHIE alone, which give
predominantly H4 alone or H3 acetylation alone respectively, is substantially
reduced, while using both JHIE and BHIE to supply the both H3 and H4
acetylation maximizes the transcription.

In contrast to the basal ING4 complex HAT activity on chromatin, which is
p53 independent, the ING4 complex-mediated transcription of chromatin is highly
dependent on p53. Histone acetylation by the ING4 complex is therefore
insufficient to potentiate transcription on its own, but in conjunction with p53
allows transcription from chromatin, potentially as a function of ING4 complex
histone acetylation. In fact, the ING4 complex-mediated effect on transcription
correlates exactly with the HAT activity of the ING4 complex. Where greater
histone acetylation is obtained by using both JHIE and BHIE complexes together,
greater transcription is also observed. Where trimethylated H3K4 enhances the
HAT activity of the ING4 complex, ING4 complex-mediated transcription in the
presence of trimethylated H3K4 is also enhanced. Finally when HAT synergy is
obtained by allowing sequential acetylation by p300 followed by the ING4
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complex, transcriptional synergy is also obtained. Altogether, these observations
provide strong, if circumstantial, evidence that the ING4 complex HAT activity,
which is enhanced by p53-dependent p300 histone acetylation and p53dependent trimethylated H3K4, is what is responsible for its effect on p53mediated transcription.

However, this does not rule out other mechanisms by which the ING4
complex might also affect p53-dependent transcription. Acetylation of nonhistone proteins could also play a role, or the ING4 complex might recruit other
proteins/protein complexes and activities, such as the MLL1 complex and its
H3K4 methylation activity. In fact, given the complexity of the transcriptional
processes and the wide array of interactions that the ING4 complex is
responsible for, it is very likely that there are other mechanisms yet to be
discovered by which the ING4 complex affects transcription.

The establishment of an in vitro transcription system from chromatin that is
dependent on both p53 and the ING4 complex is one that will be of great use in
the further study of the ING4 complex and its contributions to p53-mediated
transcription, allowing for biochemical in addition to cell based analyses of ING4
complex activity. The use of naïve (unmodified) chromatin templates in
conjunction with other histone modifiers such as p300, as analyzed here, or other
cofactors (such as SET1) known to function with p53 would allow a more
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comprehensive approach to studying p53-mediated transcription. This, in turn
would more accurately reconstitute and reflect the in vivo activities of p53 gene
activation.
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Chapter 5

Models and perspectives
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5.1 Mechanism of ING4 complex p53-dependency
The premise behind the hypothesis that ING4 acts as a p53 cofactor was
that its inhibitory effects on cell growth through cell cycle arrest and apoptosis
were dependent on p53. This premise was further supported by current studies
showing p53-dependent enrichment of ING4 and ING4 associated H3K9
acetylation at the TSS of p21 upon conditions that activate p21. However,
biochemical dissection of ING4 complex activity on chromatin revealed no
significant direct effect of p53 on the HAT activity of the ING4 complex. So while
ING4 is functionally dependent on p53 in terms of its effects in the cell, its ability
to acetylate histones in the context of chromatin is not directly dependent on p53.
How then does this functional p53 dependency come about? We propose here
two non-mutually exclusive pathways by which p53 can indirectly effect ING4
complex HAT activity and thereby, to ING4 complex-mediated activation of p53
target genes.

5.1.1 Synergy of the ING4 complex with p53-dependent p300 activity
While p53, on its own, does not affect ING4 complex HAT activity on
chromatin in any observable way, the ING4 complex and p300 together exhibit
synergistic HAT activity that is dependent on p53. The fact that optimal HAT
activity was achieved when the HATs were added sequentially, with p300 first
and BHIE second, suggests that the p53-dependent p300 HAT activity primes
the chromatin for subsequent ING4 complex-mediated histone acetylation (Fig
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17), which affects subsequent transcription. One possible explanation for this
priming can be drawn from the observation that this synergistic effect is seen
primarily with the bromodomain containing BHIE version of the ING4 complex
rather than the JHIE version of the ING4 complex which does not contain a
bromodomain. This suggests that the bromodomain recognition of a p300
acetylated lysine residue on a histone tail may be responsible for the enhanced
BHIE HAT activity observed. This might function to stabilize the protein complex
on chromatin in the same way that bromodomain recognition of acetyl-lysines
stabilizes p300 on chromatin (Tang, et al., 2013).

Another possibility for this synergistic HAT activity is based on the ING4
association with p300 (Shiseki, et al., 2003). A physical interaction between the
ING4 complex and p300 might allow an alternative pathway by which p53 could
indirectly affect ING4 complex activity. In this case, the p53 would recruit p300
which would in turn interact with the ING4 complex and enhance its activity on
chromatin.

Further investigation will be required to determine if either or both of these
possibilities are indeed responsible for the p53-dependent p300-ING4 complex
effects on histone acetylation and transcription. A bromodomain mutation would
allow analysis of its contribution to the p300-ING4 complex synergy while an
HBO1 mutation that results in inactivation of the catalytic MYST domain would
102

Fig 17. p53-dependent ING4 complex HAT activity through p300.
i) p53 binds to p53 response elements (p53 RE) and recruits p300. p300
acetylates histones and is stabilized on chromatin by p300 bromodomain-acetyl
lysine interactions.
ii) The BRPF bromodomain of the ING4 complex interacts with the acetyl-lysines
and allows additional histone acetylation by the ING4 complex. The ING4
complex may be further stabilized on chromatin by possible interactions with
p300.
Blue arrows represent histone acetylation activity. Black arrows represent
physical interactions. Dashed black arrow represents a possible (but
unconfirmed) physical interaction. ac: Histone acetylation.
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allow a more conclusive link to be made between the ING4 complex HAT activity
and its effects on both the observed HAT synergy as well its contributions to
transcription. The determination of the acetyl-lysines that are bound by the BRPF
bromodomain and whether it binds acetylated lysines in general or is restricted to
specific acetylated lysines on H3 and H4 would also be interesting.

5.1.2 Cooperativity with p53-dependent H3K4 trimethylation
While not shown here, the link between p53 and H3K4 trimethylation on
p53 target genes have been made elsewhere. What has been shown here is that
H3K4 trimethylation does positively affect ING4 complex HAT activity. This
allows for another pathway by which p53 could indirectly affect ING4 complex
HAT activity on chromatin. It has been shown that p53 recruits p300, which in
turn stabilizes the SET1 complex on chromatin and leads to trimethylation of
H3K4 (Tang, et al., 2013). As an extension to that model, the ING4 complex
could then be recruited to the chromatin through ING4 PHD finger recognition of
the trimethylated H3K4, which allows subsequent histone H3 acetylation and
transcription activation by the ING4 complex in conjunction with p53 and p300
(Fig 18).
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Fig 18. p53-dependent ING4 complex HAT activity through H3K4me3.
i) p300 is recruited to chromatin by p53 and is stabilized on the chromatin via
bromodomain-acetyl lysine interactions. The SET1 complex (SET1C) is recruited
by p53 and p300 and trimethylates H3K4.
ii) The ING4 complex binds to trimethylated H3K4 via its ING4 PHD finger,
allowing additional histone acetylation by the ING4 complex.
Blue arrow represents histone acetylation activity. Black arrows represent
physical interactions. Red arrow represents H3K4 trimethylation activity. ac:
Histone acetylation. K4me3: Trimethylated H3K4
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An interesting future experiment to consider would be to employ SET1
complex-mediated H3K4 trimethylation in conjunction with the p53-dependent,
p300-ING4 complex dependent chromatin acetylation and transcription system
used here. Such an experiment would integrate all histone modifications into one
contiguous set of reactions and allow a more cohesive conclusion to be drawn
rather than via extrapolating from individual experiments.

5.2 Expanding the ING4 complex epigenetic vocabulary
5.2.1 Simultaneous reading from differently marked histones
The multiplicity of histone readers present in the ING4 complex, some of
which read mutually exclusive histone marks (ING4 PHD recognizing
trimethylated H3K4 and the JADE and BRPF PHD1 recognizing unmethylated
H3K4) begs the question of how these multiple readers integrate their input on
chromatin. The size of the histone reading modules and the crystal structures
available for modules binding to histone tails preclude the possibility of multiple
modules reading the same histone tail at the same time due to steric hindrance.
The possibility exists, however, of simultaneous binding of multiple histone
reading modules to different histone tails, either within the same nucleosomes, or
on multiple nucleosomes.
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One intriguing possibility that this suggests is this use of the JADE/BRPF
PHD1 and the ING4 PHD fingers to simultaneously bind to nucleosomes at a
trimethylated H3K4-unmethylated H3K4 boundary. In conjunction with HBO1
HAT activity, this could be one possible mechanism by which acetylation of
histones on unmethylated H3K4 could be influenced by the trimethylation of
H3K4 on an adjacent nucleosome. This acetylation could in turn stimulate
methylation of the unmethylated H3K4 by the MLL1 or SET1 complex, providing
a pathway by which H3K4 methylation could be spread outwards from an existing
trimethylated H3K4 bearing nucleosome (Fig 19).

5.2.2 ING4-ING4/ING4-ING5 complex dimerization
The ability of the ING4 LZL region to form homodimers with the LZL
regions of other ING4 molecules and the predicted ability to form heterodimers
with the LZL regions of ING5 molecules raises the possibility of ING4-ING4 and
ING4-ING5 (as well as ING5-ING5) complex dimmers. This would dramatically
expand the number of histone binding domains and catalytic histone modifying
domains that could be assembled into a single entity. For example, a dimer that
contains both JADE as well as BRPF versions of the ING4 complex would be
possible, combining the H3 acetylation preference of BRPF complex with the H4
aceylation preference of JADE complex. A dimer that contains both HBO1 and
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Fig 19. Exploiting the H3K4me3-H3K4me0 nucleosomal boundary through
binding of the ING4 complex to adjacent H3K4me3 and H3K4me0
containing nucleosomes.
i) The ING4 complex binds to adjacent nucleosomes via ING4 PHD interactions
with H3K4me3 and JADE/BRPF PHD interactions with H3K4me0 at the
H3K4me3-H3K4me0 nucleosome boundary. The ING4 complex acetylates H3 &
H4 on the H3K4me3 nucleosome but only H4 on the H3K4me0 nucleosome.
ii) Acetylation on the H3K4me0 nucleosome allows a p300 stabilized SET1
complex to trimethylated H3K4, creating a new H3K4me3-H3K4me0 boundary.
iii) The ING4 complex binds to the newly trimethylated H3K4 nucleosome and
adjacent H3K4me0 nucleosome.
Blue arrows represents histone acetylation activity. Black arrows represent
physical interactions. Red arrow represents H3K4 trimethylation activity. ac:
Histone acetylation. K4me3: Trimethylated H3K4. K4me0: Umethylated H3K4
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MOZ/MORF would also be possible, leading to coordination between the H3 and
H4 acetylation by HBO1, and MOZ/MORF-mediated H3K14 acetylation (Ullah, et
al., 2008).

The increased availability of multiple histone binding domains would also
increase the affinity of the overall dimer for chromatin (Ruthenburg, et al.,
2007b), as well as allowing the specific recognition of a more extensive
combination of histone marks. Dimerization would likewise increase the physical
distance over which nucleosomes could be bound and modified by the dimerized
complex, compared to a single undimerized complex. Further studies looking
beyond the dimerization of ING4 to dimerization of the ING4 complex would
therefore be useful in studying the full scope of what the ING4 complex can do in
terms of coordinated recognition and modification of histones.

5.2.3 Effects of recognition of other histone marks
While this study has focused primarily on the recognition of trimethylated
H3K4 and its effects on the HAT activity of the ING4 complex, the effects of
many other histone marks that are recognized by the ING4 complex on ING4
complex activity have yet to be fully elucidated. The BRD1 bromodomain
recognition of acetylated lysines has been proposed as a possible mechanism for
the p300-ING4 complex HAT synergy, but has yet to be investigated. The
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specificity of such recognition to a particular lysine or lysines on histones has
also yet to be discovered.

Similarly, while the effect of trimethylated H3K4 recognition compared to
unmethylated recognition of H3K4 by the ING4 complex on H3 acetylation has
been examined on several specific H3 residues, the same has yet to be done for
H4, with studies to date looking at overall H4 acetylation via radiography rather
than at specific residues. An ING4 complex modulated H4 acetylation specificity
in response to unmethylated vs trimethylated recognition of H3K4 remains a
possibility to be elucidated.

Lastly, while the recognition of the JADE PHD1 and BRPF PWWP domain
to trimethylated H3K36 has been noted, no further study of the effects of such
recognition on the HAT activity of the ING4 complex has yet been conducted.
Investigating the effects of this mark on ING4 complex activity would be useful to
better understand the mechanism by which the ING4 complex mediates
transcription.
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Chapter 6

Methods and Materials

115

6.1 cDNAs
ING4 and JADE1L cDNAs were amplified from HeLa cell RNA by RTPCR. HBO1 (Gene accession number: BC032640) and hEAF6 (BG702589)
cDNAs were purchased from Open Biosystems, while BRD1 (BC030007) cDNA
was purchased from ATCC.

6.2 Antibodies
The following antibodies were used for ChIP, co-IP and immunoblots:
ING4 (Dr Zhanyun Tang, Rockefeller Univeristy), JADE1L/PHF17 (Abcam),
BRD1/BRPF2 (Abcam), HBO1 (Santa Cruz Biotechnology), hEAF6/C1orf149
(Santa Cruz Biotechnology), H3K4me3 (Abcam), H3K4me1 (Abcam), H4K8ac
(Abcam), H3K9ac (Abcam), H3K14ac (Millipore), H3K18ac (Abcam), MLL1C
(Dou, et al., 2005), RBBP5 (Bethyl Laboratories), WDR5 (Bethyl Laboratories),
ASH2L (Bethyl Laboratories) and p53 (Santa Cruz Biotechnology).

6.3 Purification and reconstitution
A stable HeLa/Tet-on cell line (Tang, et al., 2013) expressing FLAG-ING4
was obtained from Dr Zhanyun Tang. Doxoycline (Sigma) was used to induce
expressing of FLAG-ING4 for 36 hours and the treated cells lysed in SDS sample
buffer and blotted for ING4 to determine conditions where ectopic ING4
expression was approximately equal to endogenous ING4 expression. Under
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these conditions nuclear extracts were prepared from the cells as previously
described (Dignam, et al., 1983) except that extract was dialyzed to 300mM
rather than 100mM KCl. The extract was fractionated through a phosphocellulose
(Whatman P11) column equilibrated with BC300 (BC0 (20mM Tris-HCl (ph 7.9),
0.2mM EDTA, 20% glycerol, 0.2mM phenylmethylsulfonyl fluoride (PMSF) and
10mM β-mercaptoethanol) with 300mM KCl) with 0.1% NP-40, and the BC500
fraction (BC0 with 500mM KCl) containing ING4 and HBO1 was dialyzed in BC0
to a final salt concentration of 0.3M KCl. This fraction was cleared by
centrifugation and the supernatant incubated for eight hours with anti-FLAG M2
agarose (Sigma), washed three times with BC300 with 0.1% NP-40 (Sigma) and
eluted with BC150 (BC0 with 150mM KCl) with 0.1% NP-40 containing 0.3 mg/ml
3xFLAG peptide (Sigma). The complex was then analyzed by silver staining or
concentrated with an Amicon Ultra 10K centrifugal filter and sent for mass
spectrometry analysis.

cDNAs were cloned into pFASTBAC1 vectors either directly, or after
modification to include an N-terminal FLAG epitope. Baculoviruses were
generated according to the manufacturer’s instruction (Invitrogen). Sf9 cells were
infected with the desired baculoviruses and incubated for 72 hours. The infected
cells were collected and resuspended in BC300 with 0.1% NP-40 and sonicated
for 2.5 minutes in a Diagenode bioruptor. Cell debris was removed by
centrifugation and the supernatant incubated with M2 agarose beads (Sigma) for
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four hours. The complex was then washed and eluted as described for the ING4
complex purification.
The p208ML DNA template along with p300, NAP1 and the chromatin
assembly factors ACF1, ISWI and TOPO1, as well as FLAG-tagged p53 and
GST tagged p53 were purified as described (An, et al., 2004). Unmodified
recombinant histones together with histones containing the semi-synthetic
H3Kc4me3 (Simon, et al., 2007) were assembled into histone octamers and
combined with the DNA template and incubated with chromatin assembly factors
to assemble chromatin as described (An & Roeder, 2004). HeLa nucleosomes
were purified from HeLa cell nuclear pellets as described (Owen-Hughes, et al.,
1999).

6.4 Histone modification assays
HAT assays were carried out in 10mM HEPES (pH 7.9), 30mM KCl,
2.5mM DTT, 0.25mM EDTA, 5mM sodium butyrate and 5mM MgCl 2 with 2ul of
0.5mM 3H acetyl-CoA or unlabeled acetyl-CoA added together with the HATs in a
total volume of 31.5ul. For the assays on HeLa nucleosomes and free histones,
4ul ING4C, 8ul JHIE or 8ul BHIE was added to 200ng of substrate and incubated
with at 30’C for one hour (Fig 9A). For assays on chromatin, 50ng of p53 was
incubated with 95ng of DNA assembled into chromatin for 20 minutes at 27’C,
followed by addition of p300, ING4C, JHIE or BHIE and incubated for one hour at
30’C. For the titration assay 10, 20, 40 or 80ng of ING4C, 5, 10, 20 or 40ng of
118

JHIE or 40 or 60ng of BHIE, as measured by the amount of HBO1 present in the
complex were used (Fig 9D). For the time course, 10ng ING4C and 200ng p300
were used (Fig 9E), while for the other chromatin HAT assays 200ng of p300,
80ng of ING4C, 60ng JHIE and 60ng BHIE was used (Fig 9F, Fig 10C & 10D).
For the assays examining p300 and ING4 complex HAT activity, 25, 50 or 100ng
of p300, and 7.5, 15 or 30ng of JHIE or BHIE complex was used (Fig 12A &
12C).. For the KMT/HAT assay 120ng ING4C, 70ng p300 and 50ng p53 was
used and where indicated, SAM was added to a final concentration of 50µM SAM
(Fig 13B). Samples were run on a 15% acrylamide gel and analyzed by
immunoblot or autoradiography as indicated.

For the H3 peptide HAT assay, biotinylated H3 peptides with different K4
methylation states were synthesized by the Rockefeller core facility and
conjugated to streptavidin agarose beads (Thermo Scientific) by incubation of 25
µg of peptide with 25 ul of beads for 3 hours at room temperature, followed by
extensive washing with PBS (137mM NaCl, 2.7mM KCl, 10mM Na 2HPO4 and
1.8mM KH2PO4, pH 7.4) with 0.1% Triton-X (Sigma). 250ng of H3 peptide was
incubated with 2ul of 0.5mM 3H acetyl-CoA and 8ul ING4C for one hour at 30’C,
washed extensively with TBS (150mM NaCl, 2.5mM KCl, 25mM Tris-HCl, pH 8),
and the cpm measured by scintillation (Fig 10A).
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6.5 p53 coIP and in vitro binding assays
~25x106 HCT 116 cells were treated with 0.5µM doxorubicin for 24 hours
to activate p53, harvested, pelleted, then lysed by suspension in BC150 with
0.1% NP-40 and sonication on ice. The suspension was cleared by centrifugation
and precleared with Protein A sepharose (Amersham). 5ul of ING4 antibody or
IgG control antibody was then added to the supernatant and incubated overnight
at 4’C. Protein A sepharose was incubated with the supernatant for 4 hours at
4’C, then extensively three times with BC300 with 0.1% NP-40. Samples were
eluted from the beads with SDS sample buffer and analyzed by immunoblot.

For the in vitro binding assays, 1µg GST-p53 or control GST protein was
incubated with 400ng of indicated ING4 complex subunit/s in BC150 with 0.1%
NP-40 for 2 hours at 4’C. Gluthathione 4B sepharose was subsequently
incubated with the sample for 1 hour at 4’C, then washed five times with BC150
with 0.1% NP-40. Samples were eluted with SDS sample buffer and analyzed by
immunoblot.

6.6 ChIPs
ChIP assays were performed as described (Lauberth, et al., 2013) with 5ul
of antibodies and enrichment at three sites around the TSS of p21 measured by
qPCR. ING4 and H3K9ac values were normalized to the values in untreated
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Table 3. Primers used in ChIP qPCR assays.
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cells. Primers used for the qPCR are listed in Table 3. The TSS and +507
primers were adapted from Donner et al (Donner, et al., 2007)

6.7 Transcription assays
In vitro transcription assays from chromatin templates were performed
essentially as described (An & Roeder, 2004). Briefly, 40ng of DNA template
assembled into chromatin was incubated with 50ng of p53 for 20 minutes at 27’C
followed by addition of indicated HATs and acetyl-CoA and a further incubation at
30’C for one hour. 5ul of HeLa nuclear extract was then incubated with the
reaction for 15 minutes to allow PIC formation, followed by the addition of
nucleotides and a further 60 minute incubation to allow transcription. For
sequential modifications, p300 was incubated for 30 minutes, followed by
incubation with the indicated complexes for one hour at 30’C.
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